Lab Overview
The Newton-Cheh Laboratory seeks to identify the genetic contributions to common cardiovascular diseases including sudden cardiac death, drug-induced QT prolongation, and hypertension. The explosion in genetic information available from the Human Genome Project and the International HapMap project coupled with the developments of high-throughput genotyping methods and analytical and statistical approaches needed to analyze large, multidimensional datasets enable the efficient testing of the majority of human genetic variation for its contribution to human disease. We are currently studying the genetics of quantitative risk factors, including electrocardiographic QT interval duration and blood pressure, in large collections of human population-based samples and testing validated risk alleles for association with cardiovascular outcomes such as sudden cardiac death.
For patients interested in seeing Dr. Christopher Newton-Cheh in his clinical practice,
click here to find out more or call 866-MGH-8910.
|
